FDA Adverse Event Injury Summary report: N

FLEXTEND

MDR report key: 3061771 · Received April 16, 2013

Report

Report Number
2124215-2013-06197
Event Type
Injury
Date Received
April 16, 2013
Date of Event
March 20, 2013
Report Date
March 20, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS CURRENTLY AVAILABLE OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT ATRIAL (RA) LEAD EXHIBITED LOW PACING IMPEDANCES LESS THAN 200 OHMS. ALSO OBSERVED WERE SOME INAPPROPRIATE ATRIAL TACHY RESPONSE (ATR) EPISODES, AS WELL AS, THRESHOLDS GREATER THAT 2 VOLTS. SURGICAL INTERVENTION WAS PERFORMED AND THE LEAD WAS EXPLANTED AND REPLACED, AND NO ADVERSE PATIENT EFFECTS WERE REPORTED. DURING THE PROCEDURE THE PATIENT WAS ALSO UPGRADED TO A CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) SYSTEM. IT WAS REPORTED THAT THE LEAD WOULD NOT BE RETURNED AS IT WAS DISCARDED BY THE HOSPITAL STAFF.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
162580 FLEXTEND IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4087

Patients

Seq Age Sex Outcome Treatment
1 69 YR Hospitalization| L| R 5076| 4087| T167| N161| 0184| MISMATCH| 4543| 4592